Actidom Da Solution
NDC Package 63102-115-16
Package Information
Actidom Da (chlorpheniramine maleate, phenylephrine hydrochloride) solution is • do not take more than 6 doses in any 24-hour period. Children under 6 to under 12 years of age Take 2 teaspoon (10 mL), every 4 hours Children under 6 years of age Consult a doctor. This formulation utilizes a solution delivery system. Marketed by Actipharma, Llc, this product is identified by NDC 63102-115 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1429345 - chlorpheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG in 5 mL Oral Solution
- RxCUI: 1429345 - chlorpheniramine maleate 0.2 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1429345 - chlorpheniramine maleate 1 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63102 - Actipharma, Llc
- 63102-115 - Actidom Da
- 63102-115-16 - 474 mL in 1 BOTTLE, PLASTIC
- 63102-115 - Actidom Da
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63102-115-16 identifies a specific commercial package of 474 ml in 1 bottle, plastic of Actidom Da, a human over the counter drug labeled by Actipharma, Llc. This solution is formulated for oral use and contains chlorpheniramine maleate; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Actipharma, Llc on January 20, 2022. The current certification is valid through December 31, 2026.
How is this Actipharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63102011516. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.